Bharat Biotech, a company that developed indigenous vaccine cocaine against the corona virus, has said that the company will compensate if someone suffers a serious side effect after a dose. Let us know that an order has been received from Bharat Biotech (BBIL) for the purchase of 55 lakh doses of covaxin by the Government of India.
According to a memorandum of understanding signed by the vaccine recipients, ‘In case of any adverse or serious adverse event, you will be provided treatment under medically recognized standards in designated and authorized centers and hospitals by the government. If the side effect is related to the vaccine, then the company will pay for it.
Explain that in its first and second phase trials Bharat Biotech’s Covaxin has demonstrated its ability to generate antidote against Covid-19. However, the therapeutic efficacy of covaxin is yet to be determined. Its efficacy is still being studied on the basis of data from its Phase III trials.